Join our Community
Support ToI and remove all ads
Learn more
English
العربية
Français
فارسی
עברית
Get The Daily Edition
Account
Sign In
The Blogs
David Gilad
About Me
search
search
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Weekly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Community
Join our community
Sign in
About The Times of Israel
Advertise on The Times of Israel
Contact us
Get the Daily Edition
submit
Follow us
© 2025 The Times of Israel , All Rights Reserved
Terms and conditions
Privacy policy
search
The Blogs
David Gilad
Follow
NEW!
Get email alerts when this author
publishes a new article
You will receive email alerts from this author. Manage alert preferences on your
profile page
You will no longer receive email alerts from this author. Manage alert preferences on your
profile page
RSS
The Blogs
Home
Featured
Latest
Popular
Terms of Use
About Me
Apply for a Blog
Aug 14, 2019, 2:29 AM
Featured Post
Optalgin: A tale of medical woe due to lax Israeli pharmaceutical regulation
A pain reliever was banned in the US and elsewhere in the 1970s because of potentially fatal side effects; why is it available over-the-counter in Israeli pharmacies?
Load more
About Me
Rss
David Gilad, Dr. sc. nat., is a Swiss American currently living in Jerusalem.
close popup
Sign in or Register
Email address
*
Please use the following structure: example@domain.com
Continue
Or Continue with
By registering you agree to the
terms and conditions
Send me The Times of Israel Daily Edition
back
close popup
Register to continue
Email address
*
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
*
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Register
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Continue
I forgot my password
/
Send me a sign in link
Or Continue with
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete registration so you can comment.
' fill='%230E4F97'%3E%3Cg id='Group-5' transform='translate(370.000000, 11.000000)'%3E%3Cg id='avatar' transform='translate(6.000000, 4.000000)'%3E%3Ccircle id='Oval' cx='8' cy='4' r='4'%3E%3C/circle%3E%3Cpath d='M7.12864205,10 L8.87135795,10 C11.558649,10 14.0087196,11.5384024 15.1762205,13.958831 L16,15.6666667 L16,15.6666667 L15.3374858,17.5134983 C15.228016,17.8186575 14.9774027,18.051811 14.6651459,18.1389975 L8,20 L8,20 L1.33485405,18.1389975 C1.02259733,18.051811 0.771984007,17.8186575 0.662514216,17.5134983 L0,15.6666667 L0,15.6666667 L0.823779545,13.958831 C1.99128041,11.5384024 4.44135104,10 7.12864205,10 Z' id='Rectangle'%3E%3C/path%3E%3C/g%3E%3C/g%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
